<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Jean L</submitter><funding>Synaptica Ltd.</funding><pagination>6253-6272</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC6484111</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>294(16)</volume><pubmed_abstract>Many neurodegenerative diseases are characterized by amyloid deposition. In Alzheimer's disease (AD), β-amyloid (Aβ) peptides accumulate extracellularly in senile plaques. The AD amyloid cascade hypothesis proposes that Aβ production or reduced clearance leads to toxicity. In contrast, the cholinergic hypothesis argues for a specific pathology of brain cholinergic pathways. However, neither hypothesis in isolation explains the pattern of AD pathogenesis. Evidence suggests that a connection exists between these two scenarios: the synaptic form of human acetylcholinesterase (hAChE-S) associates with plaques in AD brains; among hAChE variants, only hAChE-S enhances Aβ fibrillization &lt;i>in vitro&lt;/i> and Aβ deposition and toxicity &lt;i>in vivo&lt;/i> Only hAChE-S contains an amphiphilic C-terminal d</pubmed_abstract><journal>The Journal of biological chemistry</journal><pubmed_title>&lt;i>In vivo&lt;/i> localization of human acetylcholinesterase-derived species in a β-sheet conformation at the core of senile plaques in Alzheimer's disease.</pubmed_title><pmcid>PMC6484111</pmcid><funding_grant_id>AChE peptide</funding_grant_id><pubmed_authors>Jean L</pubmed_authors><pubmed_authors>Brimijoin S</pubmed_authors><pubmed_authors>Vaux DJ</pubmed_authors></additional><is_claimable>false</is_claimable><name>&lt;i>In vivo&lt;/i> localization of human acetylcholinesterase-derived species in a β-sheet conformation at the core of senile plaques in Alzheimer's disease.</name><description>Many neurodegenerative diseases are characterized by amyloid deposition. In Alzheimer's disease (AD), β-amyloid (Aβ) peptides accumulate extracellularly in senile plaques. The AD amyloid cascade hypothesis proposes that Aβ production or reduced clearance leads to toxicity. In contrast, the cholinergic hypothesis argues for a specific pathology of brain cholinergic pathways. However, neither hypothesis in isolation explains the pattern of AD pathogenesis. Evidence suggests that a connection exists between these two scenarios: the synaptic form of human acetylcholinesterase (hAChE-S) associates with plaques in AD brains; among hAChE variants, only hAChE-S enhances Aβ fibrillization &lt;i>in vitro&lt;/i> and Aβ deposition and toxicity &lt;i>in vivo&lt;/i> Only hAChE-S contains an amphiphilic C-terminal d</description><dates><release>2019-01-01T00:00:00Z</release><publication>2019 Apr</publication><modification>2025-05-29T20:47:44.393Z</modification><creation>2025-05-29T20:47:44.393Z</creation></dates><accession>S-EPMC6484111</accession><cross_references><pubmed>30787102</pubmed><doi>10.1074/jbc.ra118.006230</doi><doi>10.1074/jbc.RA118.006230</doi></cross_references></HashMap>